Skip to main content
. 2016 Feb 9;9:79. doi: 10.1186/s13104-016-1895-8

Fig. 1.

Fig. 1

Kaplan–Meier analysis of progression-free survival (left panels) and overall survival (right panels). Kaplan–Meier estimates of survivals according to the best objective response of metastatic target sites (a, b), Heng risk score (c, d). The time to the events is given in months